Search research articles
Contact Us
Filters
Showing results (11-20 of 97) with videos related to
Page
of 10
Sort By:
Expert Review of Anticancer Therapy
|
October 30, 2014
'Charting a new course for prostate cancer' - currying favor for docetaxel in hormone-sensitive metastatic prostate cancer
Mark Voskoboynik, John Staffurth, Zafar Malik, et al.
Prostate Cancer and Prostatic Diseases
|
December 22, 2017
The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation
Megan McNamara, Christopher Sweeney, Emmanuel S Antonarakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2019
Strategies for Evaluation of Novel Imaging in Prostate Cancer: Putting the Horse Back Before the Cart
Neha Vapiwala, Michael S Hofman, Declan G Murphy, et al.
Pediatric Blood & Cancer
|
May 9, 2019
AYA testis cancer: The unmet challenge
Sara Stoneham, Matthew Murray, Benjamin Thomas, et al.
European Urology
|
April 10, 2025
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger's Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial. Eur Urol. 2025;87:468-75
Christopher Sweeney, Meng He, Matthew Wongchenko, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 29, 2020
A combined biological and clinical rationale for evaluating metastasis directed therapy in the management of oligometastatic prostate cancer
Michael J Kucharczyk, Jonathan So, Gwenaelle Gravis, et al.
Abdominal Imaging
|
November 30, 2014
Approach to risk stratification in testicular germ cell tumors: a primer for radiologists
Monica J Wood, Sree Harsha Tirumani, Christopher Sweeney, et al.
Clinical Genitourinary Cancer
|
August 31, 2017
Smoking and Disease Outcomes in Patients With Malignant Germ Cell Tumors
Elizabeth O'Donnell, Sarah C Markt, Rowan Miller, et al.
Prostate Cancer and Prostatic Diseases
|
September 5, 2020
Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastases
Bradley McGregor, Li Zhang, Kathryn P Gray, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
September 24, 2015
Relationship Between the Pathologic Subtype/Initial Stage and Microliths in Testicular Germ Cell Tumors
Farhana Sharmeen, Michael H Rosenthal, Monica J Wood, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 97) with videos related to
Sort By:
Page
of 10
Expert Review of Anticancer Therapy
|
October 30, 2014
'Charting a new course for prostate cancer' - currying favor for docetaxel in hormone-sensitive metastatic prostate cancer
Mark Voskoboynik, John Staffurth, Zafar Malik, et al.
Prostate Cancer and Prostatic Diseases
|
December 22, 2017
The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation
Megan McNamara, Christopher Sweeney, Emmanuel S Antonarakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2019
Strategies for Evaluation of Novel Imaging in Prostate Cancer: Putting the Horse Back Before the Cart
Neha Vapiwala, Michael S Hofman, Declan G Murphy, et al.
Pediatric Blood & Cancer
|
May 9, 2019
AYA testis cancer: The unmet challenge
Sara Stoneham, Matthew Murray, Benjamin Thomas, et al.
European Urology
|
April 10, 2025
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger's Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial. Eur Urol. 2025;87:468-75
Christopher Sweeney, Meng He, Matthew Wongchenko, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 29, 2020
A combined biological and clinical rationale for evaluating metastasis directed therapy in the management of oligometastatic prostate cancer
Michael J Kucharczyk, Jonathan So, Gwenaelle Gravis, et al.
Abdominal Imaging
|
November 30, 2014
Approach to risk stratification in testicular germ cell tumors: a primer for radiologists
Monica J Wood, Sree Harsha Tirumani, Christopher Sweeney, et al.
Clinical Genitourinary Cancer
|
August 31, 2017
Smoking and Disease Outcomes in Patients With Malignant Germ Cell Tumors
Elizabeth O'Donnell, Sarah C Markt, Rowan Miller, et al.
Prostate Cancer and Prostatic Diseases
|
September 5, 2020
Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastases
Bradley McGregor, Li Zhang, Kathryn P Gray, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
September 24, 2015
Relationship Between the Pathologic Subtype/Initial Stage and Microliths in Testicular Germ Cell Tumors
Farhana Sharmeen, Michael H Rosenthal, Monica J Wood, et al.
Page
of 10